It is estimated that ADPKD affects 1 in 1,000 people and slowly progresses to end-stage renal disease in about half of the individuals with PKD1 or PKD2 heterozygous mutation (Wilson, 2004). This evidence concerns the gene PKD1 and autosomal dominant polycystic kidney disease.